SEC Form 4 · accession 0001179110-18-011184
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J Coughlin
Director
Period of report
Sep 6, 2018
Accepted (ET)
Sep 7, 2018 · 8:31 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 1,300 | $190.55 | A | 7,731 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 705 | $190.56 | A | 8,436 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 27 | $190.57 | A | 8,463 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 100 | $190.58 | A | 8,563 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 356 | $190.59 | A | 8,919 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 400 | $190.60 | A | 9,319 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 200 | $190.61 | A | 9,519 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 68 | $190.62 | A | 9,587 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 100 | $190.65 | A | 9,687 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 816 | $190.66 | A | 10,503 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 222 | $190.67 | A | 10,725 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 4,889 | $190.68 | A | 15,614 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 517 | $190.64 | A | 16,131 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 6, 2018 | P | 300 | $190.63 | A | 16,431 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.